America Is Over Diagnosed and Over Medicated: Allen Frances on Huffington Post

America Is Over Diagnosed and Over Medicated: Allen Frances on Huffington Post #1

Post #125 Shortlink: http://wp.me/pKrrB-1Di

Today, Allen Frances, MD, who chaired the Task Force that had oversight of the development of DSM-IV has published the first of a series of blogs, on Huffington Post, on his concerns for DSM-5.

Huffington Post

Allen Frances | January 9, 2012
Professor Emeritus, Duke University

America Is Over Diagnosed and Over Medicated

“…The really bad news is that the bulk of psychiatry is no longer done by psychiatrists. Psychiatric medicines are most often prescribed by primary care doctors who are always busy and usually under trained in psychiatry. And their diagnostic and treatment decisions are heavily influenced by drug company advertising aimed directly at patients combined with aggressive marketing campaigns aimed at doctors.

“The result is massive overprescription of medicine for off label, untested, and inappropriate indications. Drug companies have more unregulated freedom in the U.S. than anywhere else in the world to push their product where it does not belong. Their success is measured in returns to shareholders, not benefits to patients…”

“…They call them ‘scientific hypotheses’ that can always be tested and corrected after DSM 5 is published. This is dead wrong and dangerously reckless. DSM 5 will have a dramatic effect on peoples lives and everything in it must be certified safe and scientifically sound.

“Final decisions on DSM 5 will be made soon. I will post a series of blogs highlighting its worst proposals and updating the efforts to shoot them down before they can become official…”

Read on here Allen Frances on Huff Po #1

Pity the poor American Psychiatric Association, Parts 1 and 2: Gary Greenberg

Pity the poor American Psychiatric Association, Parts 1 and 2: Gary Greenberg

Post #124 Shortlink: http://wp.me/pKrrB-1Ca

On January 03, I reported that the Licensing and Permissions department of American Psychiatric Publishing, A Division of American Psychiatric Association, served me with two “cease and desist” letters, just before Christmas, claiming use of the registered trademark DSM 5 within my site’s subdomain name was improper, in violation of United States Trademark Law, and that my unauthorized actions may subject me to contributory infringement liability including increased damages for wilful infringement.

I was requested to immediately cease and desist any and all use of the DSM 5 mark and that the DSM 5 mark is removed from the domain name http://dsm5watch.wordpress.com/.

Whether American Psychiatric Publishing might be considered to have a case against me or whether the use of the DSM 5 mark within my subdomain name might be found by a court to be legitimate under “fair use” – given that my site is non commercial, carries a clear disclaimer, with no intent to confuse, mislead or misrepresent my relationship with the APA or its publishing arm – I elected to change the site’s URL the following day.

The second letter demanded that I cease and desist immediately any and all use of the “DSM 5 mark” in the domain names of three additional internet platforms.

I do not own any of these three platforms or have any responsibility for them.

Evidently American Psychiatric Publishing’s Licensing and Permissions department omitted to establish ownership before issuing me with “cease and desist” demands and threats of legal action, on behalf of the American Psychiatric Association. I have received no apology nor explanation for their error. (I am not in a position to disclose the content of the second “cease and desist” letter since it relates to matters concerning a third party.)

Allen Frances, MD, professor emeritus at Duke, chaired the Task Force that had oversight of the development of DSM-IV and has been a fierce critic of the revision process towards the forthcoming edition of the Diagnostic and Statistical Manual of Mental Disorders, DSM-5. On Tuesday, Frances publicly supported my position in a commentary published on his DSM5 in Distress blog, hosted at Psychology Today.

Other blogging psychiatrists, allied mental health professionals and the author, Gary Greenberg, are supporting Frances in what they see as a heavy-handed, arrogant, bizarre and politically damaging move on the part of American Psychiatric Publishing’s Licensing and Permissions department in exercising trademark rights and making threats of legal action against a non commercial, responsible UK patient advocate who provides information and publishes commentary around the revision of two internationally used classification systems.

Commentaries from bloggers are being collated in this post:

Media coverage: American Psychiatric Association (APA) ”cease and desist” v DSM-5 Watch website; Legal information and resources for bloggers and site owners

Today, Gary Greenberg, author of Manufacturing Depression, and Inside the Battle to Define Mental Illness, Wired, December 27, 2010, has published a two part article on his website.

Read Part 1 here:

Pity the poor American Psychiatric Association, Part 1

Read Part Two, here, or published below, with the author’s permission:

Pity the American Psychiatric Association, Part 2

Gary Greenberg Blog

http://www.garygreenbergonline.com/

January 5th, 2012

In the last installment, we found out that the APA is trying to thread a camel through the eye of a needle. In their own view, they have to revise the DSM. To do this, they have to address the reification problem – i.e., that many of us, civilians and clinicians alike, have taken the DSM too seriously and treated the disorders it lists as actual diseases rather than fictive placeholders. To address it, they have to admit that it is a problem, and that they don’t have a solution. They have to fix the plane while it is airborne, but they don’t have the tools or the knowhow to do so, and the more it becomes clear that the plane is in trouble, and the more the mechanics are swearing and banging belowdecks, the more likely it is that the passengers will find out and start asking for a quick landing and a voucher on another airline.

So it is very important to try to keep the passengers in the dark as long as possible. Or, to put it another way, the APA has a product to protect, and the best way to do that, from a corporation’s point of view, is to control the narrative, as the pundits say, about the DSM.

Now, even before the recent events, which I’ll get to in a second, I knew this, because last year I wrote an article about the DSM revision for Wired about the argument between Allen Frances and Michael First, the major players in the DSM-IV revision, and Darrel Regier and David Kupfer, their counterparts on DSM-5. The article was no great shakes, just your usual lunchbucket magazine piece, fair and balanced and bland and forgettable as a soy hot dog with French’s mustard on it. I think Frances came out a little better, but that’s because I think he’s closer to the truth of the matter, and, as one of his colleagues has reminded me about a million times, he’s retired, so he can afford to speak truth to power. And the APA sounded at least reasonable in its willingness to acknowledge that the DSM is more provisional than it is generally made out to be.

Anyway, the forgettable magazine piece is in the process of becoming a book which will probably also be forgettable. And so I went back to my transcripts of conversations with the APA/DSM folks and of course found out all the questions I’d failed to ask and the points I’d failed to get clarified. So I emailed the APA pr apparatchicks and asked them to enlighten me. When exactly did the APA stop taking money from the drug companies for their educational programs, and how exactly was the embargo worded? And did I understand Regier correctly about a highly technical point that I won’t bore you with.

Here’s what I got back for a response.

Dear Gary,

We have received several requests from you for access to APA experts and positions on issues related to the DSM for the book you’re writing. I wanted you to know that we will not be working with you on this project. Last year we gave you free access to several of our officers and DSM experts for the article you wrote for Wired. In spite of the fact that we went to considerable lengths to work with you, the article you produced was deeply negative and biased toward the APA. Because of this track record, we are not interested in working with you further as we have no reason to expect that we would be treated any more fairly in your book than we were in the Wired article.

Now, why the APA would want to hand me such first-rate evidence of its own paranoia – and spare me having to listen to their talking points, not to mention preemptively decline to have a crack at responding to my book– is beyond me. It’s as incomprehensible as the letter itself, or at least the part where they complain that I was “biased toward” them. But I gather they think that they will make it harder for me to write my book, that maybe if they don’t cooperate I won’t do it. It is in any event evidence of an awfully thin skin, and of a bunker mentality. More disturbingly, it is evidence that they don’t really take their public trust too seriously. Especially when you contrast this to the National institutes of Mental Health, and its director Tom Insel, of whose work I’ve been much more directly critical, and who took the time to read it, and who still bent over backwards to get me an hour of face time that was cordial and fascinating. It’s enough to make you a fan of the government.

So to the recent events. Suzy Chapman is a patient advocate from the UK. Her website was an excellent compendium of information, archival material, reports, and, yes, criticism of the DSM-5. I have been using it in my research and admiring her tenacity and her fairmindedness. She has opinions but they are way in the background and neither shrill nor strident.

Chapman called her website DSM-5 and ICD Watch: Monitoring the Development of DSM-5, ICD-11 and ICD-10-CM. (The ICD’s are diagnostic systems run by the World Health Organization, and they are also under revision), and her subdomain name was

http://dsm5watch.wordpress.com

She also put in a disclaimer, made it clear that she had nothing to do with APA, that she wasn’t dispensing medical, legal, or technical advice. But that didn’t stop the APA from going after her. Not long after they got their DSM-5 trademark approved, and right before Christmas, they sent her this nice holiday card, which she’s kindly allowed me to post here, with her redactions.

Name: Redacted
Email: Redacted
Message: December 22, 2011

Suzy Chapman

http://dsm5watch.wordpress.com/

RE: DSM 5 Trademark Violation

Dear Ms. Chapman:
It has come to our attention that the website http://dsm5watch.wordpress.com/ is infringing upon the American Psychiatric Association’s trademark DSM 5 (serial number 85161695) and is in violation of federal law by using it as a domain name.

According to our records, the American Psychiatric Association has not authorized this use of the DSM 5 trademark. Consequently, this use of the DSM 5 mark is improper and is in violation of United States Trademark Law. Your unauthorized actions may subject you to contributory infringement liability including increased damages for willful infringement. We request that you immediately cease and desist any and all use of the DSM 5 mark. Furthermore, we request that the DSM 5 mark is removed from the domain name http://dsm5watch.wordpress.com/ . The American Psychiatric Association has a good-faith belief that the above-identified website’s use of the DSM 5 name and marks is not authorized by the American Psychiatric Association, its agents, or the law. I declare under penalty of perjury that the foregoing is true and correct and that I am authorized to act on behalf of the American Psychiatric Association.

Please confirm, within the next ten (10) days of the date of this letter, that you will stop using our trademark in http://dsm5watch.wordpress.com/ , and provide documentation confirming that you have. Any further use will be considered an infringement.

Thank you for your prompt cooperation in resolving this issue.

Very truly yours,

[Redacted]
Licensing and Permissions Manager American Psychiatric Publishing, A Division of American Psychiatric Association
1000 Wilson Boulevard Suite 1825 Arlington, VA 22209
E-mail: Redacted

Chapman, not in a position to fight, complied almost immediately. Her website is now available at

https://dxrevisionwatch.wordpress.com/

where you can also read about this kerfuffle in more detail.

Why the APA would make themselves into a Goliath is not clear to me. The DSM offers Paranoid Personality Disorder, but this episode makes me wish Frances hadn’t shied away from his proposal for a Self-Defeating Personality Disorder. Because it is not clear to me how they win this one. Not that I really care, at least not about the APA’s fortunes, but are they trying to prove Frances right about his recent, somewhat incendiary, claim that the APA no longer deserves the DSM franchise?

I did ask one of the APA’s trustees about this. He wrote:

As for whether the intellectual property angle was driving them to crush the lady in Great Britain or their wanting to crush her because she was being critical, I think when the history is finally known, it will be the former. Maybe we can think of someone using “DSM-5″ who is friendly and note the reaction.

I do like this idea of conducting an experiment. And he may well be correct, that this is the APA worrying about its intellectual property rather than just trying to make Suzy Chapman miserable or squash dissent. Will they go after the sites that have popped up predictably in the wake of publicity of their enforcement action, like www.dsm5sucks.com and the twitter account @dsm5nonsense (whose owner dares the APA to come after them)? But in the meantime, this only proves two points:

First, this organization is at least terribly tone deaf. Going after Suzy Chapman is sort of like Lowe’s yanking its ads from a tv show depicting Muslims as normal people – a hugely blunderous action taken to please a tiny constituency, which can’t possibly earn them anything but scorn and opprobrium. Either they don’t know how they come off or they don’t care. Either way, it’s pretty disturbingly arrogant behavior for an organization that has so much to say about how public money is spent.

Second, the APA is a corporation that, like any other, will do anything to protect itself from harm, real or imagined. And it spends a lot of time imagining dangers. That’s probably because it knows its primary product – the DSM, which accounts for ten percent of its income and a great deal of its clout – is faulty, and it knows that it doesn’t quite know how to fix it without risking making it much much worse.

[Ends]

Legal information and resources for bloggers and site owners:

1] Wipedia article: Cease and desist
http://en.wikipedia.org/wiki/Cease_and_desist

2] Wipedia article: Strategic lawsuit against public participation (SLAPP)
http://en.wikipedia.org/wiki/Strategic_lawsuit_against_public_participation

3] Electronic Frontier Foundation (EFF)
http://en.wikipedia.org/wiki/Electronic_Frontier_Foundation
http://www.eff.org/

EFF Bloggers’ Rights
https://www.eff.org/bloggers

EFF Legal Guide for Bloggers
https://www.eff.org/issues/bloggers/legal

4] Chilling Effects
http://en.wikipedia.org/wiki/Chilling_Effects_(group)
http://chillingeffects.org/

5] U.S. Trademark Law, Rules of Practice & Federal Statutes, U.S. Patent & Trademark Office, November 2011 http://www.uspto.gov/trademarks/law/tmlaw.pdf

Is DSM 5 A Public Trust Or An APA Cash Cow? Commercialism And Censorship Trump Concern For Quality by Allen Frances

Is DSM 5 A Public Trust Or An APA Cash Cow? Commercialism And Censorship Trump Concern For Quality

APA forces domain name change for DSM-5 and ICD-11 Watch site

Post #122 Shortlink: http://wp.me/pKrrB-1Ah

3 January, 2012

On December 22, with just one working day left before offices closed down for the Christmas and New Year holidays, I received two communications from the Licensing and Permissions department of American Psychiatric Publishing, A Division of American Psychiatric Association, informing me that the unauthorized use of the DSM 5 mark in my domain name is improper and in violation of United States Trademark Law.

I was advised that my actions may subject me to contributory infringement liability including increased damages for wilful infringement. I was requested to immediately cease and desist any and all use of the DSM 5 mark, remove the DSM 5 mark from my domain name and provide documentation confirming I had done so, and that any further use would be considered an infringement.

Given the difficulties of liaising from the UK with American Psychiatric Publishing and with my Californian based site hosts, WordPress, over the holiday and mindful of the implied consequences should I delay taking action, I considered I had little option but to change the site’s domain and title.

Since December 23, this site has been operating under the title Dx Revision Watch and the site’s domain name has been changed to

https://dxrevisionwatch.wordpress.com/

As a result of changing the domain name, links on websites, forums and social media platforms for posts published prior to December 23 and for pages cached on Google and other search engines before that date will no longer point to this site and will return a “site deleted” or 404 message.

If you have bookmarked or are linking to this site please update your links.

Today, on Psychology Today, Allen Frances, MD, who had chaired the DSM-IV Task Force, has blogged on the actions American Psychiatric Publishing has taken against this site:

DSM5 in Distress
The DSM’s impact on mental health practice and research.
by Allen Frances, M.D

Is DSM 5 A Public Trust Or An APA Cash Cow?
Commercialism And Censorship Trump Concern For Quality

Allen Frances, M.D. |  January 03, 2012

http://www.psychologytoday.com/blog/dsm5-in-distress/201201/is-dsm-5-public-trust-or-apa-cash-cow

Published on January 3, 2012 by Allen J. Frances, M.D. in DSM5 in Distress

DSM 5 will have a big impact on how millions of lives are led and how scarce mental health resources are spent. Getting the right diagnosis and treatment can be life enhancing, even life saving. Incorrect diagnosis can lead to the prescription of unnecessary and potentially harmful medication and to the diversion of services away from those who really need them and toward those who are better left alone. Preparing DSM 5 should be a public trust of the highest order.

But DSM 5 is also an enormously profitable commercial venture. DSMs are perpetual best sellers (at least one hundred thousand copies sold every year) netting the American Psychiatric Association yearly profits exceeding five million dollars.

From the very start of work on DSM 5, APA took unprecedented steps to protect its commercial interest – but in the process betrayed its obligation to the public trust. Work group members were recruited only on condition that they first sign confidentiality agreements – thereby squelching the free flow of ideas that is absolutely necessary to produce a quality diagnostic manual. ‘Intellectual property’ has been the priority – a safe, scientifically sound DSM 5 has been the victim.

DSM 5 commercialism and heavy handed censorship have recently assumed a new and troubling form. APA is exercising its ‘DSM 5’ trademark to unfairly stifle an extremely valuable source of information. Suzy Chapman, a patient advocate from England, runs a highly respected and authoritative site providing the best available information on the preparation of both DSM and ICD. Her writings can always be relied upon for fairness, accuracy, timeliness, and clarity. The site has gained a grateful following with over 40,000 views in its first two years.

Ms Chapman recently sent me the following email describing her David vs Goliath struggle with the APA and its disturbing implications both for DSM 5 and for internet freedom:

“Until last week, my website published under the domain name http://dsm5watch.wordpress.com/.

On December 22, I was stunned to receive two emails from the Licensing and Permissions department of American Psychiatric Publishing, claiming that the domain name my site operates under was infringing upon the DSM 5 trademark in violation of United States Trademark Law and that my unauthorized actions may subject me to contributory infringement liability including increased damages for willful infringement. I was told to cease and desist immediately all use of the DSM 5 mark and to provide documentation within ten days confirming I had done so.”

“Given my limited resources compared with APA’s deep pockets, I had no choice but to comply and was forced to change my site’s domain name to https://dxrevisionwatch.wordpress.com.

“Hits to the new site have plummeted dramatically and it will take months for traffic to recover – just at the time when crucial DSM 5 decisions are being made.”

“Was APA justified in seeking to exercise its trademark rights in this situation? Or do APA’s actions fly in the face of accepted internet trademark practice, common sense, and good public relations? I am not a lawyer, but I have made a careful study of ‘U.S. Trademark Law, Rules of Practice & Federal Statutes, U.S. Patent & Trademark Office, November 8, 2011’ and of many other available sources. My conclusion is that APA is making excessive and unwarranted claims for its DSM 5 trademark. Courts have found that using a trademark in a domain or subdomain name is ‘fair use’ if the purpose is non commercial, where there is no intent to mislead, where use of the mark is pertinent to the subject of discussion, and where it is clear that the user is not implying endorsement by, or affiliation with, the holder of the mark.”

“The home page of my site clearly defines its purpose – ‘DSM-5 and ICD-11 Watch – Monitoring the development of DSM-5, ICD-11, ICD-10-CM’ and carries this disclaimer,

‘This site has no connection with and is not endorsed by the American Psychiatric Association (APA), American Psychiatric Publishing Inc., World Health Organization (WHO) or any other organization, institution, corporation or company. This site has no affiliations with any commercial or not-for-profit organization…This site does not accept advertising, sponsorship, funding or donations and has no commercial links with any organization, institution, corporation, company or individual.'”

“It puzzles and worries me that APA would seek to suppress my clearly non commercial resource created only to provide information and commentary on the revision process of two internationally used classifications. My only purpose is to inform interested stakeholders and those patient groups whose medical and social care may potentially be impacted by proposals for changes to diagnostic categories and criteria.”

“There is a paradox here. The APA has promoted its commitment to transparency of process, but has rarely demonstrated it. Much has been made of the posting of drafts for public review and soliciting feedback. But to usefully participate in this process, patients, patient groups, and advocacy organizations need to know about proposed changes and when and by what means they can input comment during public review periods. Now, because of APA’s arbitrary actions, it will be harder for them to find the information they need – just when they most need it.”

I am surprised and saddened by APA’s ill-conceived attempt to restrict Suzy Chapman’s free expression on DSM 5. It can only be in the service of the equally unworthy goals of censorship and/or commercialism. I simply can’t imagine that anything should ever be kept secret in the preparation of a diagnostic manual and wonder what in Suzy Chapman’s web site could possibly be so frightening to APA.

Using a trademark to suppress comment is a violation of APA’s public trust to produce the best possible DSM 5. This is another indication that DSM has become too important for public health and for public policy for its revisions to be left under the exclusive control of one professional organization – particularly when that organization’s own financial future is at stake. This basic conflict of interest can be cured only by creating a new institutional framework to supervise the future DSM revisions. Censorship and commercial motivations must not warp the development of a safe and scientifically sound diagnostic manual.

[ENDS]

References:

1] Legal Guide for Bloggers:
https://www.eff.org/issues/bloggers/legal/liability/IP

2] U.S. Trademark Law, Rules of Practice & Federal Statutes, U.S. Patent & Trademark Office, November 8, 2011: http://www.uspto.gov/trademarks/law/tmlaw.pdf

3] Dx Revision Watch: https://dxrevisionwatch.wordpress.com/

4] Dr Allen Frances MD, former chair, DSM-IV Task Force, blogs at “DSM5 in Distress” on “Psychology Today”: http://www.psychologytoday.com/blog/dsm5-in-distress

5] APA’s DSM-5 Development site: http://www.dsm5.org/Pages/Default.aspx

Suzy Chapman

DSM 5 Disorganization, Disarray, and Missed Deadlines Allen Frances, Psychology Today

DSM 5 Disorganization, Disarray, and Missed Deadlines Allen Frances, Psychology Today

Post #120 Shortlink: http://wp.me/pKrrB-1zt

DSM5 in Distress
The DSM’s impact on mental health practice and research.
by Allen Frances, M.D

DSM 5 Disorganization, Disarray, and Missed Deadlines
Beware The Final Mad Rush

Allen Frances, M.D. |  December 29, 2011

Dr Dayle Jones has become one of the world’s leading experts on DSM 5 and on psychiatric diagnosis. As Chair of the American Counseling Association’s DSM 5 Task Force, she closely follows the DSM 5 process and trenchantly critiques the DSM 5 proposals (see her blogs at http://my.counseling.org/category/dayle-jones/).

Dr Jones just sent me the following alarming email: “DSM 5 keeps missing its own deadlines and the DSM 5 publication date is fast approaching. I am afraid there is insufficient time left for thoughtful preparation or adequate public input. Here’s a brief history of DSM 5’s consistent failure to deliver on time…

…Here’s a brief history of DSM 5’s consistent failure to deliver on time.

On the DSM-5 Field Trials in Academic/Large Clinic Settings: These were originally scheduled to begin in 2009, prior even to the draft proposals being reviewed and vetted by outside mental health professionals. But, after much criticism, the DSM-5 Task Force wisely postponed the start date to June 2010. Unfortunately, the Task Force then came up with an impossibly complicated field trial design that was roundly criticized for missing the relevant questions and having a completely unrealistic timetable…

…On the Routine Clinical Practice Field Trial: I have serious concerns whether this will ever get done…Finally, after these many miscues, the field trials ‘officially’ began in September 2011. In November, APA announced it was extending the field trials to March 2012 in order to recruit more participants. There’s a desperate failure motivating this extension- according to the APA flyer, out of “over 5000 clinicians” eligible to participate, only 195 have completed the training, and a mere 70 (1.4%) are enrolling patients.

This field trial is clearly a total bust.

On The Open Periods For Public Comment: APA has repeatedly bragged about the “unprecedented” open comment periods whereby clinicians can post comments about the DSM-5 proposals online during specified time periods. Ironically, the first comment period in February/April 2010 was initiated only after outside pressure insisted that all proposed revisions be reviewed and vetted by the field before field trials could begin. And, interestingly, very few substantive changes have been made in response to public comments since the first drafts were posted- despite the fact that so many DSM 5 proposals have been so heavily criticized. The final public comment period was originally scheduled for September/October 2011, but has been twice postponed because everything is so far behind- first to January/February 2012 and recently to May 2012. Given this late date, new public feedback will almost certainly have no impact whatever on DSM-5 and appears to be no more than a public relations gimmick…”

…In various blogs since, I have warned that the DSM 5 process has suffered from continued disarray- with constantly missed deadlines, reckless proposals, and a poorly written product. I have long predicted that there would be a headlong and heedless rush at the end to meet the new deadline of May 2013 – with the inevitable mistakes, inconsistencies, and poor quality…

…Given all that is undone and poorly done and the ongoing remarkable state of disarray, the May 2013 publication date for DSM 5 has itself become impossibly premature. In any sensible world there would be yet another year’s delay to clean up the current mess. But because projected DSM 5 publishing profits are essential to the meeting the projected APA budget, May 2013 will almost certainly be the one and only deadline DSM 5 will ever meet. It now seems clear that DSM 5 will be born well before its time in an impossibly ragged and possibly unusable state.

Read full article by Allen Frances on Psychology Today

When is the third stakeholder and public review of draft categories and criteria for DSM-5 scheduled?

When is the third stakeholder and public review of draft categories and criteria for DSM-5 scheduled?

Post #119 Shortlink: http://wp.me/pKrrB-1yz

Most likely not according to the schedule posted on the DSM-5 Development website.

The first stakeholder and public review of draft proposals for changes to DSM-IV categories and criteria ran for ten weeks, from February 10 to April 20, 2010. The APA reported receiving over 8,600 comments [1].

The second public review ran for just six weeks, from May 4 to June 15, 2011 (at which point it was extended a further month, to July 15). During this second review period, Task Force Chair, David Kupfer, MD, told Deborah Brauser for Medscape Medical News, that 2,100 individual comments had been submitted [2].

 

Slip slidin’ away…

According to the current DSM-5 Development Timeline, the final draft is scheduled for release in January–February 2012, although the DSM-5 Development home page states:

“In spring 2012, we will open the site for a third and final round of comments from visitors which will again be systematically reviewed by each of the work groups for consideration of additional changes.”

This article, Patient-Centered Revisions to the DSM-5, co-authored by Emily A. Kuhl, PhD, David J. Kupfer, MD, and Darrel A. Regier, MD, MPH, Virtual Mentor. December 2011, Volume 13, Number 12: 873-879.

states:

“…Given the high utility of patient and public feedback in drafting revisions thus far, a third open commenting period has been scheduled to take place in 2012, following completion of the DSM-5 field trials.”

But completion dates for field trials are slipping targets.

(See: DSM 5 in Distress: Disorganization, Disarray, and Missed Deadlines, Beware The Final Mad Rush, Allen Frances, Psychology Today, December 29, 2011).

In this November 9, 2011 report by Deborah Brauser for Medscape Medical News, DSM-5 Task Force vice-chair, Darrel Regier, MD, predicts a final public feedback period “no later than May 2012.”

APA Answers DSM-5 Critics

“…Although the routine clinical settings field trials were expected to be completed by the end of December, it has been extended to around March 2012. Dr. Regier said that this will probably push back the final public feedback period to no later than May 2012.”

So, April–May? May–June? I will update when a firm release date is published or other information received.

DSM-5 Development Timeline

References

[1] DSM-5 Development website

[2] DSM-5 Task Force Ponders Round 2 of Public Feedback: Deborah Brauser for Medscape Medical News
August 31, 2011 [Registration required to view this Medscape article.]

[3] Current DSM-5 proposals for changes to DSM-IV categories and criteria

[4] DSM-5 Development Timeline

Psychiatric Times Editor invites readership to submit views on DSM-5 for potential publication

Editor of Psychiatric Times invites its readership to submit views on DSM-5 for potential publication

Post #117 Shortlink: http://wp.me/pKrrB-1sx

Although the current DSM-5 Development Timeline has a third draft scheduled for release in January-February, 2012, for a two month period for public comment, this final draft is expected to be delayed until spring, pending completion of the DSM-5 field trials.

In this November 9, 2011 report by Deborah Brouser for Medcape Medical News, DSM-5 Task Force vice-chair, Darrel Regier, MD, says “no later than May 2012.”

 APA Answers DSM-5 Critics

“…Although the routine clinical settings field trials were expected to be completed by the end of December, it has been extended to around March 2012. Dr. Regier said that this will probably push back the final public feedback period to no later than May 2012.”

When the third and final draft has been published, a notice and links will be posted on my sites with instructions on how to register with the DSM-5 Development site for submitting feedback to the Task Force and 13 work groups.

According to Darrel Regier, Vice-Chair of the DSM-5 Task Force, the specific diagnostic categories that received most comments in the second public review of draft proposals, in May-July, 2011, were sexual and gender identity disorders, followed closely by somatic symptom disorders and anxiety disorders.

December 16, 2011

In a brief Editorial entitled The Debate Over DSM-5: We Invite Your Views, James L. Knoll IV, MD, Editor, Psychiatric Times, clarifies Psychiatric Times’s position with regard to the journal’s intent behind posting the many blogs about DSM-5 that appear on its web site.

Dr Knoll encourages and invites readers to submit their viewpoints on DSM-5 “in the spirit of collegial and scientific investigation.”

Dr Knoll writes that manuscripts and letters sent to editor@PsychiatricTimes.com will be reviewed for possible publication either in print or on www.PsychiatricTimes.com.

Read Editorial here

(Free registration is required for access to Pyschiatric Times Editorial.)

 

Related content:

DSM-5 on Psychiatric Times January 3 – December 16, 2011

December 16, 2011
The Debate Over DSM-5: We Invite Your Views

November 23, 2011
DSM-5: APA Responds to American Counseling Association Concerns

November 21, 2011
DSM-5: Petitions, Predictions, and Prescriptions

November 17, 2011
Counselors Turn Against DSM-5: Can APA Ignore 120,000 Users?

November 11, 2011
DSM-5: Living Document or Dead on Arrival?

November 10, 2011
The User’s Revolt Against DSM-5: Will It Work?

November 8, 2011
APA Responds Lamely to the Petition to Reform DSM-5

November 7, 2011
The Great DSM-5 Personality Bazaar

November 4, 2011
Why Psychiatrists Should Sign The Petition To Reform DSM-5

November 3, 2011
Why Doesn’t DSM-5 Defend Itself? Perhaps Because No Defense Is Possible

November 2, 2011
DSM-5 Will Not Be Credible Without An Independent Scientific Review

November 1, 2011
DSM-5 Against Everyone Else: Research Types Just Don’t Understand The Clinical World

October 31, 2011
What Would A Useful DSM-5 Look Like? And An Update On The Petition Drive

October 26, 2011
Petition Against DSM-5 Gets Off To Racing Start: A Game Changer?

October 24, 2011
Psychologists Petition Against DSM-5: Users Revolt Should Capture APA Attention
Several divisions of the American Psychological Association have just written an open letter highly critical of DSM-5.

October 13, 2011
Should Temper Tantrums Be Made Into A DSM-5 Diagnosis?

October 12, 2011
Do We Need a DSM-V?

September 30, 2011
PTSD, DSM-5, and Forensic Misuse

September 29, 2011
An Alternative To The DSM-5 Personality Proposals

September 21, 2011
Why Psychiatry Is Wonderful—Even If DSM-5 Isn’t

September 14, 2011
DSM-5 Proposals Should Undergo An Independent Cochrane Review Of Scientific Evidence

September 13, 2011
Warning to DSM-5: Mental Health Clinicians Can Use ICD-10-CM

August 23, 2011
The Leaders’ Report on DSM-5

August 10, 2011
DSM-5 Stubbornly Circles The Wagons Against Opposition From The Field
Bob Spitzer was prophetic 4 years ago when he warned that the closed DSM-5 process would lead to a flawed DSM-5 product…

August 5, 2011
Scandalous Off Label Use Of Antipsychotics: Another Warning For DSM-5

July 27, 2011
DSM-5 Will Further Inflate the ADD Bubble: Child Work Group Fails to Learn From Experience

July 25, 2011
The British Psychological Society Condemns DSM-5

June 8, 2011
Who Needs DSM-5? A Strong Warning Comes From Professional Counselors

May 12, 2011
DSM-5 Rejects Coercive Paraphilia: Once Again Confirming That Rape Is Not A Mental Disorder

April 28, 2011
Marijuana Withdrawal Syndrome: Should Cannabis Withdrawal Disorder Be Included in DSM-5?

April 15, 2011
The Constant DSM-5 Missed Deadlines And Their Consequences: the Future is Closing In
Aside from its reckless proposals for dangerous new diagnoses, the most characteristic thing about DSM-5 has been its remarkably poor planning…

April 13, 2011
DSM-5 and the NIMH Research Domain Criteria Project

April 11, 2011
DSM-5 Will Medicalize Everyday Worries Into Generalized Anxiety Disorder

February 25, 2011
DSM-5: When To Change and When Not to Change

February 22, 2011
Temper Tantrums, Mental disorder, and DSM-5: The Case for Caution

January 25, 2011
DSM-5 Promotes A 60% Jump In The Rate Of Alcohol Use Disorders

January 20, 2011
An Independent View of DSM-5

January 19, 2011
DSM-5: A Year End Summary

January 11, 2011
DSM-5 and Practical Consequences

January 10, 2011
Does Research Support “Craving” as a Core Symptom of Substance Use Disorders in DSM-5?

January 3, 2011
DSM-5: Dissent From Within